MedPath

University of Alberta

University of Alberta logo
🇨🇦Canada
Ownership
Private
Established
1908-01-01
Employees
10K
Market Cap
-
Website
http://www.ualberta.ca

World-First Clinical Trial Demonstrates Exercise Significantly Improves Colon Cancer Survival

A groundbreaking 17-year international clinical trial involving 889 colon cancer patients shows that structured exercise programs reduce cancer recurrence risk by 28% and death risk by 37%.

Onco-Innovations Initiates Manufacturing of PNKP Inhibitor for Preclinical Testing

Onco-Innovations has partnered with Dalton Pharma Services to begin manufacturing 50 grams of their proprietary PNKP inhibitor A83B4C63 for preclinical testing.

University of Alberta's Novel Cancer Drug Zelenirstat Receives FDA Fast-Track Designation

University of Alberta researchers have developed Zelenirstat, an innovative oral cancer medication that works by preventing cancer cell spread and starving tumors.

© Copyright 2025. All Rights Reserved by MedPath